AA
ALPS Advisors Portfolio holdings
AUM
$17.3B
This Quarter Return
+13.09%
1 Year Return
+13.43%
3 Year Return
+69.62%
5 Year Return
+161.48%
10 Year Return
+94.79%
AUM
$11.3B
AUM Growth
+$11.3B
(+10%)
Cap. Flow
-$130M
Cap. Flow
% of AUM
-1.15%
Top 10 Holdings %
Top 10 Hldgs %
43.92%
Holding
930
New
74
Increased
172
Reduced
352
Closed
28
Top Buys
| 1 |
ChargePoint
CHPT
|
$42.7M |
| 2 |
Enterprise Products Partners
EPD
|
$38.3M |
| 3 |
Shoals Technologies Group
SHLS
|
$25.8M |
| 4 |
JNPR
Juniper Networks
JNPR
|
$24M |
| 5 |
CEQP
Crestwood Equity Partners LP
CEQP
|
$23.2M |
Top Sells
| 1 |
Energy Transfer Partners
ET
|
$86.2M |
| 2 |
NBLX
Noble Midstream Partners LP
NBLX
|
$65.5M |
| 3 |
Plains All American Pipeline
PAA
|
$55M |
| 4 |
Xerox
XRX
|
$20.9M |
| 5 |
Acuity Brands
AYI
|
$20.6M |
Sector Composition
| 1 | Energy | 52.67% |
| 2 | Financials | 10.26% |
| 3 | Technology | 6.92% |
| 4 | Healthcare | 4.76% |
| 5 | Consumer Discretionary | 3.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
926
CEL-SCI Corp
CVM
$81.4M
| – | – |
-69,878
| Closed | -$1.06M |
|
927
Celldex Therapeutics
CLDX
$1.57B
| – | – |
-71,581
| Closed | -$1.48M |
|
928
Assembly Biosciences
ASMB
$183M
| – | – |
-59,743
| Closed | -$275K |
|
929
Ares Capital
ARCC
$15.7B
| – | – |
-72,000
| Closed | -$1.35M |
|
930
Aprea Therapeutics
APRE
$8.91M
| – | – |
-38,329
| Closed | -$195K |
|